언어 선택

OX40

OX40 분자 정보

영어 이름	Tumor necrosis factor receptor superfamily member 4	시판 약물 수	0
임상 약물 수	27	표적 별명	ATC35 Antigen，OX40 Antigen，ACT35，IMD16，OX40，Receptors， OX40，ACT35 antigen，TNFRSF4，CD134，TNF Receptor Superfamily Member 4，TAX Transcriptionally-Activated Glycoprotein 1 Receptor，CD134 Antigen，TXGP1L，Tumor Necrosis Factor Receptor Superfamily， Member 4，Lymphoid Activation Antigene ACT35，OX40 Homologue，Tumor necrosis factor receptor superfamily member 4，Tax-Transcriptionally Activated Glycoprotein 1 Receptor，OX40 Cell Surface Antigen，OX40L receptor
최고 연구 개발 단계	Phase 3 Clinical

영어 이름	Tumor necrosis factor receptor superfamily member 4
표적 별명	ATC35 Antigen，OX40 Antigen，ACT35，IMD16，OX40，Receptors， OX40，ACT35 antigen，TNFRSF4，CD134，TNF Receptor Superfamily Member 4，TAX Transcriptionally-Activated Glycoprotein 1 Receptor，CD134 Antigen，TXGP1L，Tumor Necrosis Factor Receptor Superfamily， Member 4，Lymphoid Activation Antigene ACT35，OX40 Homologue，Tumor necrosis factor receptor superfamily member 4，Tax-Transcriptionally Activated Glycoprotein 1 Receptor，OX40 Cell Surface Antigen，OX40L receptor
시판 약물 수	0
임상 약물 수	27
최고 연구 개발 단계	Phase 3 Clinical

OX40 제품 목록

속성
Protein (15)Cell (2)Kits (2)
제품 라이브러리
온라인 (19)
종
Human (9)Mouse (3)Cynomolgus / Rhesus macaque (3)Rat (2)Rabbit (1)Canine (1)
태그
Fc Tag (5)His Tag (5)Fc Tag & Avi Tag (1)His Tag & Avi Tag (3)Mouse IgG Fc Tag (1)- (4)
마커
Unconjugated (11)Biotin-labeled (4)- (4)

제품 번호	종	발현 시스템	제품 설명
HOT OX0-H5224	Human	HEK293	Human OX40 / TNFRSF4 / CD134 Protein, His Tag (MALS verified)
HOT OX0-H5252	Human	HEK293	Human OX40 / TNFRSF4 / CD134 Protein, Mouse IgG2a Fc Tag, low endotoxin (MALS verified)
HOT OX0-H5255	Human	HEK293	Human OX40 / TNFRSF4 / CD134 Protein, Fc Tag, low endotoxin (MALS verified)
HOT TN4-H82E4	Human	HEK293	Biotinylated Human OX40 / TNFRSF4 / CD134 Protein, Avitag™,His Tag (MALS verified) (recommended for biopanning)
HOT OX0-C82E9	Cynomolgus / Rhesus macaque	HEK293	Biotinylated Cynomolgus / Rhesus macaque OX40 / TNFRSF4 / CD134 Protein, His,Avitag™ (MALS verified)
CHEK-ATF135	Human	HEK293	Human OX40 (Luc) HEK293 Reporter Cell
CHEK-ATP053	Human	HEK293	HEK293/Human OX40 / TNFRSF4 / CD134 Stable Cell Line
EP-162	Human	-	OX40 [Biotinylated] : OX40 Ligand Inhibitor Screening ELISA Kit
FRT-P014	Human	-	Human OX40 / OX40 Ligand Inhibitor Screening Kit (TR-FRET)
OX0-H82F7	Human	HEK293	Biotinylated Human OX40 Protein, Fc,Avitag™ (MALS verified)

총 수량19

OX40분자 배경

Tumor necrosis factor receptor superfamily member 4 (TNFRSF4) is also known as ACT35 antigen, OX40L receptor, TAX transcriptionally-activated glycoprotein 1 receptor, CD antigen CD134, OX40. OX40 / TNFRSF4 contains four TNFR-Cys repeats. TNFRSF4 is receptor for TNFSF4 / OX40L / GP34 and can interacts with TRAF2, TRAF3 and TRAF5.

OX40분자 별명

TNFRSF4,OX40,CD134,OX40L receptor,ACT35,TXGP1L

항체 프로젝트 거래 플랫폼

프로젝트 이름	프로젝트 단계	분자 유형	분자 출처	질병 영역	적응증
OX40 mAb - 01	Lead	Monoclonal	Humanized Mouse	AutoImmunity	Autoimmune disease

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Rocatinlimab	KHK-4083; AMG-451	Phase 3 Clinical	Amgen Inc, Kyowa Hakko Kirin Co Ltd	Abdominal Pain; Asthma; Autoimmune Diseases; Colitis; Colitis, Ulcerative; Colonic Diseases; Dermatitis, Atopic; Digestive System Diseases; Gastrointestinal Diseases; Inflammatory Bowel Diseases; Intestinal Diseases; Prurigo Nodularis	상세
Ivuxolimab	PF-8600; PF-04518600	Phase 3 Clinical	Pfizer Inc	Bone metastases; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours; Triple Negative Breast Neoplasms	상세
INBRX-106	INBRX-106; ES-102; ES102	Phase 3 Clinical	Inhibrx	Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Head and Neck Neoplasms; Melanoma; Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms	상세
GSK3174998	GSK3174998; GSK 3174998; GSK-3174998	Phase 2 Clinical	Glaxosmithkline Plc	Multiple Myeloma; Neoplasms	상세
Telazorlimab	GBR-830; ISB-830	Phase 2 Clinical	Glenmark Pharmaceuticals Ltd	Dermatitis, Atopic	상세
Tavolimab	MEDI-0562	Phase 2 Clinical	Medimmune	Carcinoma, Ovarian Epithelial; Carcinoma, Squamous Cell; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Melanoma; Neoplasms, Squamous Cell; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck	상세
HX-111	HX-111; HX111	Phase 2 Clinical	Hanx Biopharmaceuticals (Wuhan) Co Ltd	Hematologic Neoplasms; Lymphoma; Solid tumours	상세
CS-01	CS01; CS-01	Phase 2 Clinical	Zhongshan Constimulus Bio Co Ltd	Solid tumours	상세
Brivekimig	SAR-442970; SAR442970	Phase 2 Clinical	Sanofi	Colitis, Ulcerative; Crohn Disease; Diabetes Mellitus, Type 1; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Hidradenitis Suppurativa; Inflammation; Nephrosis	상세
IMG-007	IMG-007	Phase 2 Clinical		Alopecia Areata; Dermatitis, Atopic; Eczema	상세
BAT-6026	BAT-6026	Phase 2 Clinical	Bio-Thera Solutions Ltd, Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	Autoimmune Diseases; Dermatitis, Atopic; Solid tumours	상세
Gimistotug	BGB-A445	Phase 2 Clinical	BeOne Medicines Ltd	Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Melanoma; Nasopharyngeal Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck	상세
Recombinant human anti-OX40 monoclonal antibody (Livzon Group)		Phase 1 Clinical	Livzon Pharmaceutical Group Inc	Neoplasms	상세
SL-279252	TAK-252; SL-279252	Phase 1 Clinical	Shattuck Labs Inc, Takeda Pharmaceutical Co Ltd	Adenocarcinoma; Astrocytoma; Carcinoma, Basosquamous; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms	상세
FS-120	FS-120	Phase 1 Clinical	F-Star	Neoplasm Metastasis; Neoplasms	상세
Cudarolimab	IBI-101	Phase 1 Clinical		Neoplasms; Solid tumours	상세
Revdofilimab	ABBV-368; PR-1628103	Phase 1 Clinical	Abbvie Inc	Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Neoplasms; Solid tumours; Triple Negative Breast Neoplasms	상세
SHR-1806	SHR-1806	Phase 1 Clinical	Jiangsu Hengrui Medicine Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd	Neoplasms	상세
BMS-986178	BMS-986178	Phase 1 Clinical	Bristol-Myers Squibb Company	Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Neoplasms; Solid tumours; Waldenstrom Macroglobulinemia	상세
EMB-09	EMB-09	Phase 1 Clinical	Shanghai Epimab Biotherapeutics, Inc	Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Hepatitis B, Chronic; Melanoma; Nasopharyngeal Carcinoma; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms	상세
PeptiCRAd-1	Valo-D102; PeptiCRAd-1	Phase 1 Clinical	Valor Biotherapeutics	Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Liposarcoma, Myxoid; Neoplasms; Osteosarcoma; Sarcoma; Sarcoma, Synovial; Skin Melanoma; Triple Negative Breast Neoplasms	상세
Cenzestotug	YH-002	Phase 1 Clinical		Solid tumours	상세
SAR-446422	SAR446422; SAR-446422	Phase 1 Clinical	Sanofi	Autoimmune Diseases	상세
STAR-0310	ISB-830-X8; STAR-0310; STR-310	Phase 1 Clinical	Ichnos Sciences Inc	Dermatitis, Atopic	상세
HFB-3010	HFB-301001; HFB-3010	Phase 1 Clinical	HiFiBiO Therapeutics	Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Melanoma; Sarcoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Uterine Neoplasms	상세
HLX-51	HLX-51	Phase 1 Clinical		Lymphoma; Solid tumours	상세
MEDI-6469	MEDI-6469; AGX-051	Phase 1 Clinical	AgonOx Inc, Astrazeneca Plc, Providence Cancer Center, Providence Health & Services	Colorectal Neoplasms; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Melanoma; Metastatic breast cancer; Neoplasms; Prostatic Neoplasms; Solid tumours	상세